These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37589737)

  • 1. Eplerenone improves hyperglycemia and sympathetic excitation in chronic renocardiac syndrome in rats.
    Wu CJ; Li YH; Wu FZ; Chen HH
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):1081-1092. PubMed ID: 37589737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.
    Fujihara CK; Kowala MC; Breyer MD; Sena CR; Rodrigues MV; Arias SCA; Fanelli C; Malheiros DM; Jadhav PK; Montrose-Rafizadeh C; Krieger JE; Zatz R
    Sci Rep; 2017 Aug; 7(1):7899. PubMed ID: 28801620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
    Nishihara M; Takesue K; Hirooka Y
    Auton Neurosci; 2017 May; 204():88-97. PubMed ID: 27729205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
    Arai K; Tsuruoka H; Homma T
    Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of rat model of cardiorenal syndrome by transabdominal subtotal nephrectomy].
    Cao H; Ji TW; Lan Q; Lin F; Dong Y; Xu AJ; Liu J; Ding HY; Fan HM; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):447-452. PubMed ID: 30786340
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease.
    Beraldo JI; Benetti A; Borges-Júnior FA; Arruda-Junior DF; Martins FL; Jensen L; Dariolli R; Shimizu MH; Seguro AC; Luchi WM; Girardi ACC
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway.
    Han Y; Xian Y; Gao X; Qiang P; Hao J; Yang F; Shimosawa T; Chang Y; Xu Q
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109396. PubMed ID: 36461595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.
    Homma T; Sonoda H; Manabe K; Arai K; Mizuno M; Sada T; Ikeda M
    Am J Physiol Renal Physiol; 2012 Mar; 302(6):F750-61. PubMed ID: 22160776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.
    Granata A; Clementi A; Virzì GM; Brocca A; de Cal M; Scarfia VR; Zanoli L; Ronco C; Corrao S; Malatino L
    Eur J Intern Med; 2016 May; 30():1-6. PubMed ID: 26961461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling.
    Zhang MJ; Gu Y; Wang H; Zhu PF; Liu XY; Wu J
    Eur Rev Med Pharmacol Sci; 2016; 20(2):345-54. PubMed ID: 26875907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
    Rodriguez-Perez JC; Losada A; Anabitarte A; Cabrera J; Llobet J; Palop L; Plaza C
    J Pharmacol Exp Ther; 1997 Oct; 283(1):336-44. PubMed ID: 9336341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease with comorbid cardiac dysfunction exacerbates cardiac and renal damage.
    Liu S; Wang BH; Kelly DJ; Krum H; Kompa AR
    J Cell Mol Med; 2018 Jan; 22(1):628-645. PubMed ID: 28994186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
    Kolkhof P; Jaisser F; Kim SY; Filippatos G; Nowack C; Pitt B
    Handb Exp Pharmacol; 2017; 243():271-305. PubMed ID: 27830348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats.
    Paterno JC; Bergamaschi CT; Campos RR; Higa EM; Soares MF; Schor N; Freire AO; Teixeira VP
    Kidney Blood Press Res; 2012; 35(5):355-64. PubMed ID: 22473039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy.
    Fujihara CK; De Nucci G; Zatz R
    J Am Soc Nephrol; 1995 Jan; 5(7):1498-507. PubMed ID: 7535572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone inhibits UUO-induced lymphangiogenesis and cardiac fibrosis by attenuating inflammatory injury.
    Chen G; Chang Y; Xiong Y; Hao J; Liu L; Liu Z; Li H; Qiang P; Han Y; Xian Y; Shimosawa T; Wang X; Yang F; Xu Q
    Int Immunopharmacol; 2022 Jul; 108():108759. PubMed ID: 35428023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy.
    Yin J; Lu Z; Wang F; Jiang Z; Lu L; Miao N; Wang N
    J Cell Mol Med; 2016 Jun; 20(6):1106-17. PubMed ID: 26923216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.